Pharmacogenomic Testing
Pharmacogenomic (PGx) testing identifies genetic variations that code for drug-metabolizing enzymes, transporters, and receptors. Changes in genetic function can impact how an individual will respond to specific medications.
![Doctor 3](https://genemarkersllc.com/wp-content/uploads/2023/03/Doctor-3-compress.jpg)
Benefits of PGx Testing
![Benefits of PGx Testing Graphic](https://genemarkersllc.com/wp-content/uploads/2023/02/Benefits-of-PGx-Testing-Graphic-1024x344.png)
Test Panels
Test Report
Our test report offers the unique benefit of being thorough, yet easy to read. The report incorporates the most up-to-date clinical guidance from key scientific and government organizations including Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Federal Drug Administration (FDA).
Highlights:
![Screenshot (896)](https://genemarkersllc.com/wp-content/uploads/2024/02/Screenshot-896-234x300.png)
Testing Process
![PGx workflow website](https://genemarkersllc.com/wp-content/uploads/2023/02/PGx-workflow-website-1-800x426.png)
Billing Policy
Genemarkers is committed to providing patients with quality service. This includes ensuring a clear understanding of the billing process and access to a manageable payment arrangement. Most insurance plans, including Medicare and Medicaid, offer limited coverage of the test.